Periodontal regeneration with enamel matrix derivative in one human experimental defect
Regulatory Update (April 2026): DSIP (also referred to as Emideltide) is one of seven peptides scheduled for FDA Pharmacy Compounding Advisory Committee review on July 24, 2026
In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals
McCarty MF, OKeefe JH, DiNicolantonio JJ
Across dozens of studies, daily astaxanthin doses between 4mg and 12mg have been linked to improvements in skin hydration, elasticity, and UV resilience, as well as benefits for eye comfort, exercise recovery, and cognitive performance.1 2 3 5 6 Lower doses (46mg per day) often support skin and eye outcomes, but research suggests 12mg daily may unlock even broader effects.1 7 13 At 12mg, trials show improved endurance performance including faster cycling time trials and reduced muscle-soreness markers.3 8 Other studies point to enhanced cognitive function and sleep quality, benefits that tend to appear near the upper end of the dosing range.4 9 Taken together, these findings helped establish 12mg per day as the most compelling astaxanthin dose in the scientific literature
.png.jpg)
